A
ACAD icon

AlphaQuest’s Acadia Pharmaceuticals ACAD Stock Holding History

AlphaQuest’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,794
Closed -$769K – 17
2025
Q4 		$769K Sell
28,794
-3,457
-11% -$82.6K 0.04% 561
2025
Q3 		$688K Buy
+32,251
New +$763K 0.05% 601
2025
Q2 		– Sell
-9,208
Closed -$153K – 1993
2025
Q1 		$153K Sell
9,208
-4,303
-32% -$78.2K 0.02% 1113
2024
Q4 		$248K Buy
13,511
+9,991
+284% +$161K 0.03% 783
2024
Q3 		$54.1K Buy
3,520
+1,047
+42% +$17.5K ﹤0.01% 1396
2024
Q2 		$40.2K Sell
2,473
-6,745
-73% -$109K 0.01% 1124
2024
Q1 		$170K Buy
9,218
+7,965
+636% +$197K 0.03% 687
2023
Q4 		$39.2K Buy
+1,253
New +$29.9K 0.01% 909

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return